Comparison of the Solubility and Pharmacokinetics of Sildenafil Salts
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jung, Si-Young | - |
dc.contributor.author | Seo, Youn-Gee | - |
dc.contributor.author | Kim, Gun Kook | - |
dc.contributor.author | Woo, Jong Soo | - |
dc.contributor.author | Yong, Chul Soon | - |
dc.contributor.author | Choi, Han-Gon | - |
dc.date.accessioned | 2021-06-23T11:05:00Z | - |
dc.date.available | 2021-06-23T11:05:00Z | - |
dc.date.issued | 2011-03 | - |
dc.identifier.issn | 0253-6269 | - |
dc.identifier.issn | 1976-3786 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/erica/handle/2021.sw.erica/38224 | - |
dc.description.abstract | To develop sildenafil lactate, a salt form of sildenafil with improved solubility and bioavailability of poorly water-soluble sildenafil base, this salt form was prepared using a spray dryer. Its solubility and pharmacokinetics in rabbits were evaluated compared with sildenafil base and sildenafil citrate. Sildenafil lactate improved the solubility of sildenafil in various solvents including distilled water compared with sildenafil citrate. It provided higher AUC and C-max and, shorter t(1/2) values than did the other materials, indicating that it improved the oral bioavailability of sildenafil in rabbits. Our results suggest that sildenafil lactate would be useful to deliver sildenafil in a pattern that allows fast absorption and late metabolism. Furthermore, the plasma concentration at 0.25 h in sildenafil lactate was similar to the C, value at T-max (0.5 h) in sildenafil citrate. Thus, sildenafil lactate might provide a faster onset of action and immediate erection compared with sildenafil citrate, the conventional drug. | - |
dc.format.extent | 4 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | PHARMACEUTICAL SOC KOREA | - |
dc.title | Comparison of the Solubility and Pharmacokinetics of Sildenafil Salts | - |
dc.type | Article | - |
dc.publisher.location | 대한민국 | - |
dc.identifier.doi | 10.1007/s12272-011-0313-y | - |
dc.identifier.scopusid | 2-s2.0-79959923176 | - |
dc.identifier.wosid | 000289120300014 | - |
dc.identifier.bibliographicCitation | ARCHIVES OF PHARMACAL RESEARCH, v.34, no.3, pp 451 - 454 | - |
dc.citation.title | ARCHIVES OF PHARMACAL RESEARCH | - |
dc.citation.volume | 34 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 451 | - |
dc.citation.endPage | 454 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.subject.keywordPlus | PHOSPHODIESTERASE-5 INHIBITORS | - |
dc.subject.keywordPlus | ERECTILE DYSFUNCTION | - |
dc.subject.keywordPlus | BIOAVAILABILITY | - |
dc.subject.keywordPlus | CITRATE | - |
dc.subject.keywordPlus | ENHANCEMENT | - |
dc.subject.keywordPlus | IBUPROFEN | - |
dc.subject.keywordPlus | RATS | - |
dc.subject.keywordAuthor | Sildenafil lactate | - |
dc.subject.keywordAuthor | Solubility | - |
dc.subject.keywordAuthor | Pharmacokinetics | - |
dc.identifier.url | https://link.springer.com/article/10.1007%2Fs12272-011-0313-y | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
55 Hanyangdeahak-ro, Sangnok-gu, Ansan, Gyeonggi-do, 15588, Korea+82-31-400-4269 sweetbrain@hanyang.ac.kr
COPYRIGHT © 2021 HANYANG UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.